Home > Insider Trading > Filing (0001104659-16-106698)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1157602	Vitae Pharmaceuticals Inc	VTAE	Pharmaceutical Preparations (2834)	043567753

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1202285	Jr J Donald Hayden	C/O Vitae Pharmaceuticals, Inc. 502 West Office Center Dr. Fort Washington PA 19034		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2016-03-21	1,935	$3.45	1,935	No	4	M	Direct
Common Stock	Acquisiton	2016-03-21	14,195	$3.45	14,195	No	4	M	Direct
Common Stock	Disposition	2016-03-21	16,130	$7.42	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2016-03-21	1,935	$0.00	1,935	$3.45
Common Stock	Stock Option (Right to Buy)	Disposition	2016-03-21	14,195	$0.00	14,195	$3.45

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2016-03-28	No	4	M	Direct
0		2016-03-28	No	4	M	Direct

Footnotes

The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 28, 2015.
The option vested over three years of service following March 29, 2006, with 50% vesting upon completion of one year of service and in 2 equal annual installments thereafter.
The option vested over four years of service following March 29, 2006, with 25% vesting upon completion of one year of service and in 36 equal monthly installments thereafter.